2021
DOI: 10.1007/s00406-021-01284-6
|View full text |Cite
|
Sign up to set email alerts
|

Determining prognostic variables of treatment outcome in obsessive–compulsive disorder: effectiveness and its predictors in routine clinical care

Abstract: The objectives of this study were to investigate the naturalistic effectiveness of routine inpatient treatment for patients with obsessive–compulsive disorder (OCD) and to identify predictors of treatment outcome. A routinely collected data set of 1,596 OCD inpatients (M = 33.9 years, SD = 11.7; 60.4% female) having received evidence-based psychotherapy based on the cognitive–behavioral therapy (CBT) in five German psychotherapeutic clinics was analyzed. Effect sizes (Hedges' g) were calculated for several out… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 102 publications
(116 reference statements)
0
5
0
Order By: Relevance
“…Recent studies of intensive programs published after that meta-analysis have reported largely similar mean reductions in the Y-BOCS [ 106 , 108 - 110 ]. Response rates have ranged from 43 to 79% and remission from 26 to 58% [ 113 , 114 ]. Exit interviews with participants reveal four major themes related to intensive programs: (a) validation in speaking with others with experience of OCD; (b) less impact from their symptoms and re-engaging in activities; (c) intensity and necessity of ERP for recovery and the support of the team; and (d) personal and program-related challenges and satisfaction [ 115 ].…”
Section: How Should Psychotherapies Be Deployed For Ocd?mentioning
confidence: 99%
“…Recent studies of intensive programs published after that meta-analysis have reported largely similar mean reductions in the Y-BOCS [ 106 , 108 - 110 ]. Response rates have ranged from 43 to 79% and remission from 26 to 58% [ 113 , 114 ]. Exit interviews with participants reveal four major themes related to intensive programs: (a) validation in speaking with others with experience of OCD; (b) less impact from their symptoms and re-engaging in activities; (c) intensity and necessity of ERP for recovery and the support of the team; and (d) personal and program-related challenges and satisfaction [ 115 ].…”
Section: How Should Psychotherapies Be Deployed For Ocd?mentioning
confidence: 99%
“…First, many of the of the studies had used only one follow-up examination (Bloch et al, 2014;Cabedo et al, 2010;Eisen et al, 2010), which limits the ability to infer the effect of a certain predictor on the course of OCD (Bloch, 2017). In addition, most studies have focused largely on demographic and clinical prognostic variables, while neglecting other, potentially meaningful social or psychological determinants (Herzog et al, 2021;Van Oudheusden et al, 2018). Furthermore, most of the prediction studies were conducted within the context of controlled clinical trials; therefore, including OCD patients who received pharmacotherapy and/or CBT, and naturalistic studies were less common (Bloch, 2017;Cherian et al, 2014).…”
Section: Anzjp Articlesmentioning
confidence: 99%
“…Controlled clinical trials have demonstrated that the majority of patients receiving cognitive-behavioral therapy (CBT) based on exposure and response prevention (ERP) and/or pharmacotherapy experience significant improvement in their symptoms (Bloch et al, 2014; Sookman et al, 2021). Unfortunately, among patients who come to clinical attention, only about 40% receive OCD-tailored treatment and only 10% receive evidence-based treatment (Herzog et al, 2021; Hirschtritt et al, 2017; Torres et al, 2007). Furthermore, prospective studies that examined the long-term outcome of OCD patients receiving evidence-based treatment demonstrated varied long-term remission rates, ranging from 17% to 65% (Bloch et al, 2014; Cherian et al, 2014; Eisen et al, 2013; Marcks et al, 2011; Micali et al, 2010; Sharma et al, 2014; Van Oppen et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…After all, most anxiety-related studies on the course of treatment involve a single anxiety disorder ( e.g. , Herzog et al, 2022; Hunt et al, 2022; Probst et al, 2022), and the occasional studies that do compare treatment course of different anxiety-related disorders mainly concern a combined sample (depressive and anxiety disorders, e.g. , Rayner et al, 2022; participants with and without treatment, e.g.…”
mentioning
confidence: 99%